Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Niesvizky R, Badros AZ, Costa LJ, Ely SA, Singhal SB, Stadtmauer EA, et al. Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. Leuk Lymphoma. 2015;56(12):3320-8.

Urvalek AM, Osei-Sarfo K, Tang X-, Zhang T, Scognamiglio T, Gudas LJ. Identification of Ethanol and 4-Nitroquinoline-1-Oxide Induced Epigenetic and Oxidative Stress Markers During Oral Cavity Carcinogenesis. Alcohol Clin Exp Res. 2015;39(8):1360-72.

Correction to Supporting Information for Talantova et al., Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A. 2015;112(28):E3751-2.

Storch E, Mark T, Avecilla S, Pagan C, Rhodes J, Shore T, et al. A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration. Transfusion. 2015;55(8):2010-6.

Audrito V, Serra S, Brusa D, Mazzola F, Arruga F, Vaisitti T, et al. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood. 2015;125(1):111-23.

Haas T, Spielmann N, Dillier C, Cushing M, Siegmund S, Krüger B. Comparison of conventional ROTEM® cups and pins to the ROTEM® cup and pin mini measuring cells (MiniCup). Scand J Clin Lab Invest. 2015;75(6):470-5.

Finnerty BM, Kleiman DA, Scognamiglio T, Aronova A, Beninato T, Fahey TJ, et al. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol. 2015;22(4):1200-6.

Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat Genet. 2015;47(11):1346-51.

Gerke TA, Martin NE, Ding Z, Nuttall EJ, Stack EC, Giovannucci E, et al. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC. Prostate. 2015;75(16):1926-33.

Yang C, Boyson CA, Di Liberto M, Huang X, Hannah J, Dorn DC, et al. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer Res. 2015;75(9):1838-45.